Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Enterprise Value

Rigel Pharmaceuticals Enterprise Value Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Enterprise Value from 2010 to 2020.
  • Rigel Pharmaceuticals Enterprise Value for the quarter ending November 11, 2020 was $494m a 8.55% increase of 42m year over year
  • Rigel Pharmaceuticals Enterprise Value for the last 12 months ending November 11, 2020 was $494m a 8.55% increase of 42m year over year
  • Rigel Pharmaceuticals Annual Enterprise Value for 2020 was $494m a 6.16% increase of 30m from 2019
  • Rigel Pharmaceuticals Annual Enterprise Value for 2020 was $463m a 0.36% increase of 2m from 2019
  • Rigel Pharmaceuticals Annual Enterprise Value for 2020 was $462m a 2.20% increase of 10m from 2019
Other Valuation Metrics:
  • Rigel Pharmaceuticals Market Cap for the quarter ending March 03, 2018 was $521m a 35.88% increase of 187m year over year
  • Rigel Pharmaceuticals Price / Book for the quarter ending March 03, 2018 was 5.16 a 23.02% increase of 1.19 year over year
View Chart On Koyfin

Quarterly RIGL Enterprise Value Data

11/2020$494m
11/2020$463m
11/2020$462m
11/2020$452m
11/2020$433m
11/2020$428m
11/2020$419m
11/2020$433m
11/2020$431m
11/2020$433m

Annual RIGL Enterprise Value Data

2020$494m
2020$463m
2020$462m
2020$452m
2020$433m
2020$428m
2020$419m
2020$433m
2020$431m
2020$433m